Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | CTSL | P07711 | 7/20 | 0.55 |
| ▸ | CTSK | P43235 | 5/20 | 0.55 |
| ▸ | CTSB | P07858 | 4/20 | 0.55 |
| ▸ | CTSS | P25774 | 4/20 | 0.55 |
| ▸ | TACR1 | P25103 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5929949 | 0.90 | ALDH1A1 (0.60) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL3303033 | 0.90 | ITGB3 (0.56) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL8785267 | 0.88 | ALDH1A1 (0.74) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL8785257 | 0.88 | ALDH1A1 (0.74) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL7285798 | 0.88 | ALDH1A1 (0.74) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL5859423 | 0.84 | CTSL (0.56) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL12952246 | 0.83 | CTSL (0.69) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL14338213 | 0.83 | ALDH1A1 (0.67) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL22758566 | 0.83 | ALDH1A1 (0.67) | ALDH1A1ALOX15CTSLCTSKCTSB | |
| SCHEMBL14338217 | 0.82 | ALDH1A1 (0.66) | ALDH1A1ALOX15CTSLCTSKCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100099898-A1 | Processes and Intermediates For Preparing Benzyle Epoxides | ELAN PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099898-A1 | Processes and Intermediates For Preparing Benzyle Epoxides | VKORC1, EPOR, POR | ALDH1A1 1965/4885ALOX15 863/4885CTSL 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.